Physician profile
Jillian D Moore
NPI 1144684085
$1,617.92
in general payments reported to CMS, 2019-2025
30 companies · $17.94 in 2025
The $17.94 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $30.62 · 2020: $176 · 2021: $546 · 2022: $172 · 2023: $338 · 2024: $337 · 2025: $17.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $693.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $236.08 | 2020-2023 | |
| Astellas Pharma US INC | $123.82 | 2023-2024 | Veozah, Myrbetriq |
| Coopersurgical, INC. | $106.11 | 2020-2024 | Paragard T 380a |
| Exeltis, USA INC. | $84.97 | 2021-2024 | Slynd |
| Biogen, INC. | $81.94 | 2024 | Zurzuvae |
| Organon LLC | $81.91 | 2023-2025 | Nexplanon |
| Hologic Sales and Service, LLC | $79.63 | 2022-2024 | Aptima, Thinprep 2000 Processor, Third Wave |
| Therapeuticsmd, INC. | $71.35 | 2020-2022 | |
| Channel Medsystems, INC. | $70.06 | 2023 | |
| Pfizer INC. | $66.05 | 2021-2023 | |
| Evofem Biosciences, INC. | $63.81 | 2021 | |
| Agile Therapeutics, INC. | $61.28 | 2021-2023 | Twirla |
| Amgen INC. | $58.78 | 2020-2022 | |
| Shield Therapeutics INC | $48.83 | 2024 | |
| Daiichi Sankyo INC. | $47.77 | 2020-2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $38.32 | 2021 | |
| Merck Sharp & Dohme LLC | $34.46 | 2021-2024 | Gardasil 9, Gardasil |
| Mayne Pharma Commercial LLC | $33.98 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $31.12 | 2019-2021 | |
| Avion Pharmaceuticals | $27.95 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.95 | 2021 | |
| Gynesonics, INC. | $22.44 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Millicent US INC | $21.92 | 2021 | |
| Sumitomo Pharma America, INC. | $19.12 | 2023 | Myfembree |
| Celgene Corporation | $17.33 | 2021 | |
| Kyowa Kirin, INC. | $15.81 | 2019 | |
| Exact Sciences Corporation | $14.48 | 2023 | Cologuard Collection Kit |
| Zyla Life Sciences, INC. | $11.80 | 2020 | |
| Covidien LP | $11.46 | 2020 | |
| Myovant Sciences INC. | $11.39 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.